|
PFDN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.989700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.619600E-03 |
| Normal-vs-Stage2 |
1.519830E-01 |
| Normal-vs-Stage3 |
5.922600E-03 |
| Normal-vs-Stage4 |
9.245900E-02 |
| Stage1-vs-Stage2 |
8.816000E-01 |
| Stage1-vs-Stage3 |
8.307900E-02 |
| Stage1-vs-Stage4 |
2.776200E-01 |
| Stage2-vs-Stage3 |
1.976570E-01 |
| Stage2-vs-Stage4 |
3.024600E-01 |
| Stage3-vs-Stage4 |
9.553000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.405000E-03 |
| Normal-vs-AfricanAmerican |
2.402200E-03 |
| Normal-vs-Asian |
5.771600E-01 |
| Caucasian-vs-AfricanAmerican |
4.828600E-01 |
| Caucasian-vs-Asian |
9.480000E-01 |
| AfricanAmerican-vs-Asian |
7.423600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.099900E-03 |
| Normal-vs-Female |
2.682000E-03 |
| Male-vs-Female |
5.083400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.152300E-02 |
| Normal-vs-Extreme_Weight |
2.275200E-03 |
| Normal-vs-Obese |
1.971800E-02 |
| Normal-vs-Extreme_Obese |
3.028400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.820800E-01 |
| Normal_Weight-vs-Obese |
8.155000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.616400E-01 |
| Extreme_Weight-vs-Obese |
4.564400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.796400E-01 |
| Obese-vs-Extreme_Obese |
9.294600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.275400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.81749999997416E-06 |
| Normal-vs-Age(61-80Yrs) |
1.906650E-01 |
| Normal-vs-Age(81-100Yrs) |
1.480380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.367600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.050000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.835600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.806900E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.995200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.277000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.810100E-04 |
| Normal-VS-Type2 PRCC |
6.601100E-03 |
| Normal-VS-KIRP CIMP |
5.100100E-02 |
| Normal-VS-Unclassified PRCC |
6.430200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.367600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.403850E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.519000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.962700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.899000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.381500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.888200E-02 |
| Normal-vs-N1 |
9.123300E-03 |
| Normal-vs-N2 |
8.714200E-01 |
| N0-vs-N1 |
2.373000E-01 |
| N0-vs-N2 |
4.824200E-01 |
| N1-vs-N2 |
2.337400E-01 |
|
|
